EpiVario Secures Exclusive Worldwide License for Novel Technologies and Drugs for Memory-Related Psychiatric Diseases from University of Pennsylvania

Company acquires full rights, in all fields, for novel drug to treat memory-related psychiatric disorders, such as post-traumatic stress disorder (PTSD)

Read More

Share this

Comments are closed.